[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

de Mendonça et al., 2009 - Google Patents

Tumor necrosis factor‐alpha levels after surgical anti‐infective mechanical therapy for peri‐implantitis: a 12‐month follow‐up

de Mendonça et al., 2009

Document ID
12399798456826367845
Author
de Mendonça A
Santos V
César‐Neto J
Duarte P
Publication year
Publication venue
Journal of periodontology

External Links

Snippet

Background: The aim of the present case series was to evaluate the effects of a surgical anti‐ infective mechanical therapy for peri‐implantitis on clinical parameters and tumor necrosis factor‐alpha (TNF‐α) levels at 12 months post‐therapy. Methods: Ten patients with peri …
Continue reading at aap.onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Similar Documents

Publication Publication Date Title
Duarte et al. Effect of anti‐infective mechanical therapy on clinical parameters and cytokine levels in human peri‐implant diseases
Afacan et al. Gingival crevicular fluid and salivary HIF‐1α, VEGF, and TNF‐α levels in periodontal health and disease
Ata-Ali et al. Clinical, microbiological, and immunological aspects of healthy versus peri-implantitis tissue in full arch reconstruction patients: a prospective cross-sectional study
Ataoglu et al. Interleukin‐1β, tumor necrosis factor‐α levels and neutrophil elastase activity in peri‐implant crevicular fluid: Correlation with clinical parameters and effect of smoking
Konopka et al. Effect of scaling and root planing on interleukin‐1β, interleukin‐8 and MMP‐8 levels in gingival crevicular fluid from chronic periodontitis patients
Garlet et al. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease
Pourabbas et al. Effects of photodynamic therapy on clinical and gingival crevicular fluid inflammatory biomarkers in chronic periodontitis: A split‐mouth randomized clinical trial
Kawasaki et al. Effects of aging on RANKL and OPG levels in gingival crevicular fluid during orthodontic tooth movement
Erdemir et al. Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL‐6 and TNF‐α in patients with chronic periodontitis
Rakic et al. Bone loss biomarkers associated with peri‐implantitis. A cross‐sectional study
Casado et al. Interleukins 1β and 10 expressions in the periimplant crevicular fluid from patients with untreated periimplant disease
Taba Jr et al. Diagnostic biomarkers for oral and periodontal diseases
Ataoğlu et al. Interleukin‐1β and tumour necrosis factor‐α levels in periapical exudates
Emecen‐Huja et al. Peri‐implant versus periodontal wound healing
Prapulla et al. Gingival crevicular fluid VEGF levels in periodontal health and disease
Darabi et al. Comparison of the levels of tumor necrosis factor-α and interleukin-17 in gingival crevicular fluid of patients with peri-implantitis and a control group with healthy implants
Duzagac et al. Is obesity associated with healing after non‐surgical periodontal therapy? A local vs. systemic evaluation
de Mendonça et al. Tumor necrosis factor‐alpha levels after surgical anti‐infective mechanical therapy for peri‐implantitis: a 12‐month follow‐up
Zekeridou et al. Effect of initial periodontal therapy on gingival crevicular fluid cytokine profile in subjects with chronic periodontitis
Machtei et al. Comparison of clinical, radiographic and immunological parameters of teeth and different dental implant platforms
Ata-Ali et al. Clinical, microbiologic, and host response characteristics in patients with peri-implant mucositis.
Gürkan et al. Adjunctive subantimicrobial dose doxycycline: Effect on clinical parameters and gingival crevicular fluid transforming growth factor‐β1 levels in severe, generalized chronic periodontitis
Khoury et al. Early wound healing following one‐stage dental implant placement with and without antibiotic prophylaxis: a pilot study
Vemanaradhya et al. Effect of 1.2% of simvastatin gel as a local drug delivery system on Gingival Crevicular Fluid interleukin-6 & interleukin-8 levels in non surgical treatment of chronic periodontitis patients
Acar et al. Effects of oral prophylaxis including tongue cleaning on halitosis and gingival inflammation in gingivitis patients—a randomized controlled clinical trial